Su Liu

Su Liu is an experienced professional in the field of translational medicine, currently serving as the Global Translational Medicine Lead at Astellas Pharma since April 2024. Prior to this role, Su Liu held the position of Principal Scientist and Senior Scientist at Astellas Gene Therapies from December 2021 to March 2024. Su Liu also worked as a Senior Scientist II at Ambys Medicines, and from October 2016 to April 2021, Su Liu was employed at BioMarin Pharmaceutical Inc. as both a Scientist II and Scientist I. Su Liu began a research career as a Postdoctoral Fellow at the Buck Institute for Research on Aging from November 2010 to September 2016. Su Liu received education from the University of Rochester School of Medicine and Dentistry.